These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7662969)

  • 21. BAX 335 hemophilia B gene therapy clinical trial results: potential impact of CpG sequences on gene expression.
    Konkle BA; Walsh CE; Escobar MA; Josephson NC; Young G; von Drygalski A; McPhee SWJ; Samulski RJ; Bilic I; de la Rosa M; Reipert BM; Rottensteiner H; Scheiflinger F; Chapin JC; Ewenstein B; Monahan PE
    Blood; 2021 Feb; 137(6):763-774. PubMed ID: 33067633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FIX-Triple, a gain-of-function factor IX variant, improves haemostasis in mouse models without increased risk of thrombosis.
    Kao CY; Lin CN; Yu IS; Tao MH; Wu HL; Shi GY; Yang YL; Kao JT; Lin SW
    Thromb Haemost; 2010 Aug; 104(2):355-65. PubMed ID: 20539913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of An Orally Effective Factor IX-Transferrin Fusion Protein for Hemophilia B.
    Xie C; Wang Z; Su Y; Wang J; Shen WC
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31861459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hemophilia B Leyden and once mysterious cis-regulatory mutations.
    Funnell AP; Crossley M
    Trends Genet; 2014 Jan; 30(1):18-23. PubMed ID: 24138812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A factor IX-deficient mouse model for hemophilia B gene therapy.
    Wang L; Zoppè M; Hackeng TM; Griffin JH; Lee KF; Verma IM
    Proc Natl Acad Sci U S A; 1997 Oct; 94(21):11563-6. PubMed ID: 9326649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterisation of factor IX with a glycine-to-valine missense mutation at residue 190 in a patient with severe haemophilia B.
    Kao CY; Lin CN; Yang YL; Hamaguchi N; Yang SJ; Shen MC; Kao JT; Lin SW
    Thromb Haemost; 2011 Apr; 105(4):616-26. PubMed ID: 21301787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic fusion to albumin improves the pharmacokinetic properties of factor IX.
    Metzner HJ; Weimer T; Kronthaler U; Lang W; Schulte S
    Thromb Haemost; 2009 Oct; 102(4):634-44. PubMed ID: 19806248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Double mutation, a 2-bp deletion and Val211Ile, in the blood coagulation factor IX gene of a patient with severe hemophilia B].
    Seita I; Shinozawa K; Otaki M; Fujita S; Suzuki T; Amano K; Inaba H; Fukutake K
    Rinsho Byori; 2009 May; 57(5):417-24. PubMed ID: 19522246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synergy between transcription factors DBP and C/EBP compensates for a haemophilia B Leyden factor IX mutation.
    Picketts DJ; Lillicrap DP; Mueller CR
    Nat Genet; 1993 Feb; 3(2):175-9. PubMed ID: 8499951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcriptional control of the factor IX gene: analysis of five cis-acting elements and the deleterious effects of naturally occurring hemophilia B Leyden mutations.
    Picketts DJ; Mueller CR; Lillicrap D
    Blood; 1994 Nov; 84(9):2992-3000. PubMed ID: 7949171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating human factor IX produced in keratin-promoter transgenic mice: a feasibility study for gene therapy of haemophilia B.
    Alexander MY; Bidichandani SI; Cousins FM; Robinson CJ; Duffie E; Akhurst RJ
    Hum Mol Genet; 1995 Jun; 4(6):993-9. PubMed ID: 7544665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An A to T transversion at position -5 of the factor IX promoter results in hemophilia B.
    Picketts DJ; D'Souza C; Bridge PJ; Lillicrap D
    Genomics; 1992 Jan; 12(1):161-3. PubMed ID: 1733855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A codon 338 nonsense mutation in the factor IX gene in unrelated hemophilia B patients: factor IX338 New York.
    Driscoll MC; Bouhassira E; Aledort LM
    Blood; 1989 Aug; 74(2):737-42. PubMed ID: 2752145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hormonal and nutritional control of the fatty acid synthase promoter in transgenic mice.
    Soncini M; Yet SF; Moon Y; Chun JY; Sul HS
    J Biol Chem; 1995 Dec; 270(51):30339-43. PubMed ID: 8530458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic modification of donor hepatocytes improves therapeutic efficacy for hemophilia B in mice.
    Wu YM; Kao CY; Huang YJ; Yu IS; Lee HS; Lai HS; Lee PH; Lin CN; Lin SW
    Cell Transplant; 2010; 19(9):1169-80. PubMed ID: 20412633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of ten new mutations by screening the gene encoding factor IX of Danish hemophilia B patients.
    Nielsen LR; Scheibel E; Ingerslev J; Schwartz M
    Thromb Haemost; 1995 May; 73(5):774-8. PubMed ID: 7482402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Employing a gain-of-function factor IX variant R338L to advance the efficacy and safety of hemophilia B human gene therapy: preclinical evaluation supporting an ongoing adeno-associated virus clinical trial.
    Monahan PE; Sun J; Gui T; Hu G; Hannah WB; Wichlan DG; Wu Z; Grieger JC; Li C; Suwanmanee T; Stafford DW; Booth CJ; Samulski JJ; Kafri T; McPhee SW; Samulski RJ
    Hum Gene Ther; 2015 Feb; 26(2):69-81. PubMed ID: 25419787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of recombinant human factor IX expressed in transgenic mice and in derived trans-immortalized hepatic cell lines.
    Jallat S; Perraud F; Dalemans W; Balland A; Dieterle A; Faure T; Meulien P; Pavirani A
    EMBO J; 1990 Oct; 9(10):3295-301. PubMed ID: 2209546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of a Hemophilia B Mouse Model with Platelet-Targeted Expression of Factor IX Padua.
    Li B; Wu Z; Xu W; Han W; Liu J; Wang D; Zhang G
    Hum Gene Ther; 2021 May; 32(9-10):506-516. PubMed ID: 33764159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rat transition nuclear protein 2 regulatory region directs haploid expression of reporter gene in male germ cells of transgenic mice.
    Nayernia K; Böhm D; Topaloglu O; Schlüter G; Engel W
    Mol Reprod Dev; 2001 Apr; 58(4):368-75. PubMed ID: 11241772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.